Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group

Am J Cardiol. 1996 Nov 1;78(9):1074-6. doi: 10.1016/s0002-9149(96)00543-7.

Abstract

The central laboratory provides International Normalized Ratio results in close agreement with the local laboratory for monitoring the anticoagulant effect of low-dose warfarin. A central laboratory may have practical advantages for patients in rural areas that lack laboratory facilities for anticoagulant monitoring.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Anticoagulants / blood*
  • Anticoagulants / therapeutic use
  • Clinical Trials as Topic
  • Female
  • Humans
  • Laboratories*
  • Male
  • Middle Aged
  • Partial Thromboplastin Time
  • Patient Care Planning
  • Prospective Studies
  • Specimen Handling*
  • Warfarin / blood*
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin